Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 22 studies | 26% ± 10% | |
fibroblast | 16 studies | 22% ± 5% | |
smooth muscle cell | 13 studies | 17% ± 2% | |
pericyte | 13 studies | 20% ± 4% | |
endothelial cell of lymphatic vessel | 10 studies | 22% ± 5% | |
epithelial cell | 7 studies | 32% ± 12% | |
basal cell | 7 studies | 29% ± 9% | |
capillary endothelial cell | 6 studies | 16% ± 1% | |
ciliated cell | 6 studies | 25% ± 7% | |
astrocyte | 6 studies | 28% ± 10% | |
oligodendrocyte | 6 studies | 27% ± 7% | |
connective tissue cell | 5 studies | 23% ± 5% | |
abnormal cell | 4 studies | 27% ± 7% | |
microglial cell | 4 studies | 23% ± 5% | |
myofibroblast cell | 4 studies | 26% ± 6% | |
oligodendrocyte precursor cell | 4 studies | 33% ± 10% | |
goblet cell | 4 studies | 29% ± 11% | |
macrophage | 4 studies | 23% ± 6% | |
progenitor cell | 3 studies | 18% ± 2% | |
club cell | 3 studies | 26% ± 3% | |
lymphocyte | 3 studies | 18% ± 2% | |
Mueller cell | 3 studies | 20% ± 3% | |
hepatocyte | 3 studies | 38% ± 24% | |
GABAergic neuron | 3 studies | 45% ± 7% | |
glutamatergic neuron | 3 studies | 49% ± 10% | |
enteroendocrine cell | 3 studies | 23% ± 7% | |
transit amplifying cell | 3 studies | 25% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3802.33 | 1445 / 1445 | 100% | 30.64 | 183 / 183 |
lung | 100% | 3829.01 | 578 / 578 | 100% | 24.41 | 1154 / 1155 |
breast | 100% | 4359.46 | 459 / 459 | 99% | 32.25 | 1110 / 1118 |
prostate | 100% | 3946.32 | 245 / 245 | 99% | 27.42 | 498 / 502 |
brain | 99% | 1846.11 | 2620 / 2642 | 100% | 31.05 | 703 / 705 |
uterus | 100% | 5813.04 | 170 / 170 | 98% | 22.35 | 451 / 459 |
intestine | 100% | 3668.66 | 966 / 966 | 98% | 22.40 | 517 / 527 |
pancreas | 100% | 1921.39 | 327 / 328 | 98% | 22.06 | 175 / 178 |
thymus | 100% | 3855.74 | 653 / 653 | 98% | 22.08 | 592 / 605 |
ovary | 100% | 5972.79 | 180 / 180 | 98% | 14.78 | 420 / 430 |
adrenal gland | 100% | 3107.05 | 258 / 258 | 97% | 18.16 | 224 / 230 |
bladder | 100% | 4608.33 | 21 / 21 | 97% | 21.05 | 490 / 504 |
stomach | 100% | 2652.69 | 359 / 359 | 97% | 22.15 | 277 / 286 |
kidney | 100% | 2423.02 | 89 / 89 | 96% | 23.98 | 869 / 901 |
liver | 100% | 2363.15 | 226 / 226 | 95% | 19.25 | 384 / 406 |
skin | 100% | 5542.46 | 1809 / 1809 | 93% | 24.17 | 437 / 472 |
adipose | 100% | 4545.66 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4383.86 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 2577.61 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2670.12 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 26.62 | 45 / 45 |
heart | 99% | 2277.25 | 854 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 9.22 | 25 / 29 |
eye | 0% | 0 | 0 / 0 | 68% | 9.42 | 54 / 80 |
peripheral blood | 29% | 596.42 | 265 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0003161 | Biological process | cardiac conduction system development |
GO_0001657 | Biological process | ureteric bud development |
GO_0002051 | Biological process | osteoblast fate commitment |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0007165 | Biological process | signal transduction |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0060048 | Biological process | cardiac muscle contraction |
GO_0045669 | Biological process | positive regulation of osteoblast differentiation |
GO_0030509 | Biological process | BMP signaling pathway |
GO_0030218 | Biological process | erythrocyte differentiation |
GO_0060395 | Biological process | SMAD protein signal transduction |
GO_0009880 | Biological process | embryonic pattern specification |
GO_1902045 | Biological process | negative regulation of Fas signaling pathway |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0007281 | Biological process | germ cell development |
GO_0030154 | Biological process | cell differentiation |
GO_0001880 | Biological process | Mullerian duct regression |
GO_0009653 | Biological process | anatomical structure morphogenesis |
GO_0060348 | Biological process | bone development |
GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
GO_0051216 | Biological process | cartilage development |
GO_0071407 | Biological process | cellular response to organic cyclic compound |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0071141 | Cellular component | SMAD protein complex |
GO_0005739 | Cellular component | mitochondrion |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0071144 | Cellular component | heteromeric SMAD protein complex |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0017151 | Molecular function | DEAD/H-box RNA helicase binding |
GO_0070411 | Molecular function | I-SMAD binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SMAD5 |
Protein name | SMAD family member 5 Mothers against decapentaplegic homolog (MAD homolog) (Mothers against DPP homolog) (SMAD family member) Mothers against decapentaplegic homolog 5 (MAD homolog 5) (Mothers against DPP homolog 5) (JV5-1) (SMAD family member 5) (SMAD 5) (Smad5) (hSmad5) |
Synonyms | DKFZp781O1323 hCG_41402 DKFZp781C1895 MADH5 |
Description | FUNCTION: Transcriptional regulator that plays a role in various cellular processes including embryonic development, cell differentiation, angiogenesis and tissue homeostasis . Upon BMP ligand binding to their receptors at the cell surface, is phosphorylated by activated type I BMP receptors (BMPRIs) and associates with SMAD4 to form an heteromeric complex which translocates into the nucleus acting as transcription factor . In turn, the hetero-trimeric complex recognizes cis-regulatory elements containing Smad Binding Elements (SBEs) to modulate the outcome of the signaling network . Non-phosphorylated SMAD5 has a cytoplasmic role in energy metabolism regulation by promoting mitochondrial respiration and glycolysis in response to cytoplasmic pH changes . Mechanistically, interacts with hexokinase 1/HK1 and thereby accelerates glycolysis . . |
Accessions | D6RBB4 ENST00000509297.6 ENST00000513418.1 ENST00000511116.5 H0YAM3 ENST00000545279.6 H0YAK7 D6R9D4 Q68DB7 ENST00000507637.1 ENST00000507118.5 ENST00000506223.1 D6RIZ9 ENST00000545620.5 Q99717 |